Intervention1: Revamilast: Oral

2 trials

Sponsors

Glenmark Pharmaceuticals Ltd

Conditions

Health Condition 1: null- Chronic Persistent AsthmaHealth Condition 1: null- Rheumatoid Arthritis

Phase 2

A clinical trial to study the effects of Revamilast in patients with Rheumatoid Arthritis

Active, not recruitingCTRI/2011/09/001990

Glenmark Pharmaceuticals LtdHealth Condition 1: null- Rheumatoid Arthritis

Target: 406Updated: 2021-11-24

A clinical trial to study the effects of Revamilast in patients with Chronic Persistent Asthma

Active, not recruitingCTRI/2011/09/001993

Glenmark Pharmaceuticals LtdHealth Condition 1: null- Chronic Persistent Asthma

Target: 448Updated: 2021-11-24